VPAC1 Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of VPAC1 monoclonal antibodies for research focused on vasoactive intestinal peptide receptor 1 (VPAC1). VPAC1 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). VPAC1 is a crucial receptor involved in numerous physiological processes, including the regulation of circadian rhythms, modulation of immune responses, and the promotion of smooth muscle relaxation. The role of VPAC1 in neurobiology and gastrointestinal function makes it an important target for research into various diseases, including metabolic disorders and cancer. Understanding VPAC1 signaling mechanisms can provide insights into potential therapeutic strategies. Researchers worldwide rely on VPAC1 monoclonal antibodies to advance their studies in cellular signaling pathways. VPAC1 monoclonal antibodies enable detailed investigation of receptor distribution, activation, and regulation across different tissue types. The specificity and reliability of VPAC1 monoclonal antibodies from Santa Cruz Biotechnology support researchers in making meaningful contributions to scientific understanding of human health and disease.